A telephone intervention trial was associated with improvement in glaucoma medication adherence in both the treatment group and the control group but, when the two groups were compared, interactive telephone calls and tailored print materials did not s…
Author: The Medical News
Viewpoints: Praise for insurers’ move to keep consumer protections; Supreme Court’s reputation falters
UnitedHealthcare, one of the nation’s largest health insurers, announced this week that it would keep some of the popular benefits and consumer protections required by the federal health care law even if the Supreme Court strikes down all or part of it…
Cerebral damage, ROP may increase risk of visual impairment in extremely preterm children
Cerebral damage and retinopathy of prematurity appear to be independently associated with visual impairment among preschool children who were born extremely premature, according to a report published Online First by Archives of Ophthalmology, a JAMA Ne…
RVO advances PresbyLens into final phase of trial for treatment of presbyopia
ReVision Optics, Inc. (RVO), a leader in implantable inlay technology to treat presbyopia, announces the advancement of its proprietary product PresbyLens into the final phase of its U.S. clinical trial under an Investigational Device Exemption
VisionCare expands CentraSight telescope implant provider teams
VisionCare Ophthalmic Technologies, Inc., developer of the first FDA-approved ophthalmic telescope implant indicated to improve vision in patients with end-stage age-related macular degeneration (AMD), announced today the expansion of its CentraSight
Nrf2-KEAP1 protein may play a role in diabetic retinopathy
A Wayne State University researcher believes a protein that fails to reach the nucleus of retinal cells may play a role in causing eye disease in people with diabetes.
Ocular pulse amplitude reliable, safe screening test for carotid artery stenosis
A simple eye test may someday offer an effective way to identify patients who are at high risk for stroke, say researchers at the University of Zurich. They showed that a test called ocular pulse amplitude (OPA) can reliably detect carotid artery steno…
CDI introduces MyCell Services
Cellular Dynamics International, Inc. (CDI), the world’s largest commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells, today announced the launch of its MyCell Services.
DODAC to discuss ThromboGenics’ new BLA for ocriplasmin intravitreal injection
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin…
Study investigates optical treatments to slow myopia progression in children
Research by an optometrist at the University of Houston (UH) supports the continued investigation of optical treatments that attempt to slow the progression of nearsightedness in children.
BioInvent, ThromboGenics to regain global rights to TB-403 from Roche
ThromboGenics NV and co-development partner BioInvent International announce today that they will regain global rights to TB-403 from Roche.
BioInvent, ThromboGenics announce results from TB-402 Phase IIb trial on VTE
ThromboGenics NV and co-development partner BioInvent International announce today the results from a Phase IIb trial comparing TB-402, a long acting anticoagulant, against rivaroxaban, an oral anticoagulant.
New ‘ESASO Course Series’ for ophthalmologists
In the new book series ‘ESASO Course Series’, the essentials of the courses of the European School for Advanced Studies in Ophthalmology (ESASO) are made available to interested ophthalmologists, optometrists, technicians and residents all over the world.
Mayo Clinic offers new technology for treatment of dry eye
Mayo Clinic in Arizona is the first medical center in Arizona and the Southwest to provide a new technology that treats dry eye by targeting blocked eyelid glands. Blocked glands can inhibit production of oil that is necessary for healthy tears needed …
DHA prevents age-related vision loss in lab tests
An omega-3 fatty acid found in fish, known as DHA, prevented age-related vision loss in lab tests, demonstrates recently published medical research from the University of Alberta.
Mass. Eye and Ear Cataract Master bridges gap between wet lab training and patient surgery
Phacoemulsification cataract surgery is one of the most frequently performed eye surgeries in the United States, with 1.5 million procedures performed each year. It is also one of the most complex procedures to learn. A new, highly innovative, computer…
Positive results from Sanofi and Regeneron’s SAR236553/REGN727 Phase 2 trial on heFH
Sanofi and Regeneron Pharmaceuticals, Inc. today announced additional positive results from a Phase 2 trial of SAR236553/REGN727 in patients with heterozygous familial hypercholesterolemia (heFH).
Optogenetic Therapies for Vision workshop to be held on June 1
The Foundation Fighting Blindness and Massachusetts Eye and Ear will host the Optogenetic Therapies for Vision workshop on Friday, June 1, from 8 a.m.-6 p.m., in Boston.
Scientists determine genetic sequences of all 12 vancomycin-resistant staph strains
National Institutes of Health-funded scientists have determined the genetic sequences of all 12 available strains of Staphylococcus aureus bacteria resistant to vancomycin-an antibiotic of last resort-and have demonstrated that resistance arose indepen…
Cooper Green installs Medsphere’s OpenVista EHR
MedsphereSystems Corporation and Cooper Green Mercy Hospital today announced that Cooper Green has gone live on Medsphere’s OpenVista open source electronic health record (EHR).